Delivery Order SPE2DE21D7020-SPE2D625F3QHY
- Not listed
- Boston Scientific Corp has been awarded a delivery order valued at $6,175.00 for agent drug-coated balloons under the Defense Health Agency's Medical Supply Chain contract vehicle. The award, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. This delivery order...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- Boston Scientific Corp has been awarded a $48,157.20 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons. The contract, issued on September 8, 2025, carries an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a non-set-aside award, indicating open competition in the federal marketplace, and...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $18,918.66 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on June 27, 2025. The contract is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of July 7, 2025. The place of performance is located in Marlborough, MA, where Boston Scientific...
- Boston Scientific Corp has been awarded a delivery order valued at $9,001.72 for agent drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on September 4, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside contract is funded by the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. Drug-coated balloons are specialized...
- The U.S. Department of Defense's Medical Supply Chain awarded a fixed-price delivery order valued at $17,802.20 to Boston Scientific Corp for agent drug-coated balloons. Issued on September 10, 2025, with an ultimate completion date of September 17, 2025, this delivery order represents a competitive award with no set-aside designation. The contract will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes the specialized...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $13,356.93 for drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract was funded by the Defense Health Agency's Medical Supply Chain and represents an open competition award with no set-aside designation. Drug-coated balloons are...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F3QHYDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $8,150.20 for agent drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 16, 2025, with a completion date of September 19, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be executed at Boston Scientific's Marlborough, Massachusetts facility, the company's global headquarters for medical device development and manufacturing. This delivery order represents a continuation of Boston Scientific's established role as a critical supplier of advanced cardiovascular intervention technologies to federal healthcare agencies. The company maintains an extensive portfolio of federal contracts with the Department of Veterans Affairs and Defense Health Agency, supplying specialized medical devices including drug-coated balloons, stents, catheters, and diagnostic equipment. The drug-coated balloon delivery under this order supports the Defense Health Agency's medical supply chain requirements for minimally invasive cardiovascular interventions, contributing to the agency's provision of advanced medical technologies across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 9/16/25 |